Embera NeuroTherapeutics

    OverviewSuggest Edit

    Embera NeuroTherapeutics is a pharmaceutical company developing treatments for addiction. It offers a medication aimed at treating addiction by moderating activity in the stress response system. The company serves patients with cocaine and tobacco use disorders, as well as other substance abuse issues.
    TypePrivate
    Founded2005
    Websiteemberaneuro.com

    Latest Updates

    Employees (est.) (Jun 2020)5
    Cybersecurity ratingAMore

    Key People/Management at Embera NeuroTherapeutics

    John B. Beaird

    John B. Beaird

    Director
    Gary Connor

    Gary Connor

    Vice President, Clinical Operations
    Joseph F. Lovett

    Joseph F. Lovett

    Director
    Show more

    Embera NeuroTherapeutics Financials and Metrics

    Summary Metrics

    Founding Date

    2005

    Embera NeuroTherapeutics latest funding size

    $2 m
    Show all financial metrics

    Embera NeuroTherapeutics Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    96/100

    SecurityScorecard logo

    Embera NeuroTherapeutics Online and Social Media Presence

    Embed Graph

    Embera NeuroTherapeutics Frequently Asked Questions

    • When was Embera NeuroTherapeutics founded?

      Embera NeuroTherapeutics was founded in 2005.

    • Who are Embera NeuroTherapeutics key executives?

      Embera NeuroTherapeutics's key executives are John B. Beaird, Gary Connor and Joseph F. Lovett.

    • How many employees does Embera NeuroTherapeutics have?

      Embera NeuroTherapeutics has 5 employees.

    • Who are Embera NeuroTherapeutics competitors?

      Competitors of Embera NeuroTherapeutics include Inovio Pharmaceuticals, Emisphere Technologies and Intercept Pharmaceuticals.